US 12239677
Therapeutic bacteriophage compositions for treating Staphylococcus infection
granted A61KA61K2300/00A61K31/395
Quick answer
US patent 12239677 (Therapeutic bacteriophage compositions for treating Staphylococcus infection) held by Armata Pharmaceuticals, Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Armata Pharmaceuticals, Inc.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2300/00, A61K31/395, A61K31/43, A61K31/47